+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Statin loading before percutaneous coronary intervention: proposed mechanisms and applications



Statin loading before percutaneous coronary intervention: proposed mechanisms and applications



Future Cardiology 6(5): 579-589



Statin therapy reduces the risk of cardiovascular events in patients with coronary artery disease. Recent in vitro and in vivo studies demonstrated a LDL-independent action of these class of drugs, which appears in modulating endothelial function, inflammation and thrombosis. Periprocedural myocardial infarction and contrast-induced nephropathy after percutaneous coronary intervention (PCI), associated with worse outcome on long-term follow-up, are both complications related to inflammatory pathogenetic mechanisms. Randomized studies demonstrated a beneficial effect of short-term statin pretreatment in reducing periprocedural cardiac marker release in patients undergoing PCI. Statin therapy before elective PCI reduces periprocedural myocardial infarction in patients with stable angina. Furthermore, an acute loading with a high dose of atorvastatin prevents myocardial damage in patients with acute coronary syndromes undergoing early PCI (<48 h). In patients already on chronic statin therapy, a reload with high-dose statins was associated with a significant improvement on 30-day major adverse cardiac event rates. Furthermore, statin therapy at the time of PCI significantly decreased the incidence of contrast-induced nephropathy. This evidence suggests an 'upstream administration' of short-term, high-dose statins in all patients undergoing PCI.

(PDF emailed within 0-6 h: $19.90)

Accession: 055911112

Download citation: RISBibTeXText

PMID: 20932108

DOI: 10.2217/fca.10.77


Related references

Statin loading in patients undergoing percutaneous coronary intervention for acute coronary syndromes: a new pleiotropic effect?. Current Medical Research and Opinion 26(4): 839-842, 2010

Statin loading before percutaneous coronary intervention to reduce periprocedural myocardial infarction. Cardiology in Review 20(6): 319-324, 2013

Efficacy of high-dose atorvastatin loading before primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: the STATIN STEMI trial. Jacc. Cardiovascular Interventions 3(3): 332-339, 2010

High dose statin loading prior to percutaneous coronary intervention decreases cardiovascular events: a meta-analysis of randomized controlled trials. Catheterization and Cardiovascular Interventions 85(1): 53-60, 2015

The effects and mechanisms of high loading dose rosuvastatin therapy before percutaneous coronary intervention in patients with acute coronary syndrome. International Journal of Cardiology 167(5): 2350-2353, 2014

Dental pain and oral health-related quality of life in individuals with severe dental anxiety. Acta Odontologica Scandinavica: 1-6, 2018

The prognostic value of very low admission LDL-cholesterol levels in ST-segment elevation myocardial infarction compared in statin-pretreated and statin-naive patients undergoing primary percutaneous coronary intervention. International Journal of Cardiology 167(2): 458-463, 2014

Effect of previous statin therapy in patients with acute coronary syndrome and percutaneous coronary intervention. Korean Circulation Journal 41(8): 458-463, 2011

Pre-percutaneous coronary intervention statin therapy: is it necessary?. American Heart Journal 168(2): E11-E11, 2014

Intensive cholesterol lowering with statin improves the outcomes of percutaneous coronary intervention in patients with acute coronary syndrome. Chinese Medical Journal 122(6): 659-664, 2009

Current statin usage for patients with acute coronary syndrome undergoing percutaneous coronary intervention: multicenter survey in Korea. Clinical Cardiology 35(11): 700-706, 2013

Effect of n-3 Polyunsaturated Fatty Acids on Regression of Coronary Atherosclerosis in Statin Treated Patients Undergoing Percutaneous Coronary Intervention. Korean Circulation Journal 46(4): 481-489, 2016

Prehospital statin therapy and one-year mortality in patients with stable coronary artery disease undergoing percutaneous coronary intervention. European Journal of Internal Medicine 24(2): 145-150, 2013

Intensive statin therapy for Chinese patients with coronary artery disease undergoing percutaneous coronary intervention ISCAP study. 2012

Preprocedural statin therapy in percutaneous coronary intervention. Annals of PharmacoTherapy 41(10): 1687-1693, 2007